Design, Synthesis, and Bioactivity Evaluation of Novel Rosin Diterpenoid Derivatives as Potential Anti‐glioma Agents
Chemistry & Biodiversity · 2023
DOI: 10.1002/cbdv.202300942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Jiayi Ou und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangdong Pharmaceutical University, 280 Outer Ring East Road, University City, Guangzhou, Guangdong Province. Hauptthemen laut MEDLINE: Glioma, Diterpenes, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Guangdong Pharmaceutical University-Special Innovation Project of Guangdong Education Department, General Colleges and Universities in Guangdong Province, Guangdong Provincial Bureau of traditional Chinese Medicine.
Abstract (Originalsprache)
Glioma is the most common brain tumor and its treatment options are limited. Abietic acid and dehydroabietic acid are tricyclic diterpenoid oxygen compounds with strong lip solubility and anti‐glioma activity. In this study, novel rosin diterpenoid derivatives were designed and synthesized using abietic acid and dehydrogenated abietic acid as lead compounds and their activities against T98G, U87MG, and U251 cells were evaluated by CCK‐8 methods. The in vivo activity of compounds with stronger activity in vitro was preliminarily studied through the Zebrafish model. The results showed that the IC 50 values of B6 , B8 , B10 , and B12 were 11.47 to 210.6 μM, which were exhibited higher antiproliferative potency against T98G, U87MG, and U251. The scratch experiment showed that B12 inhibited the migration of T98G in a time‐dependent and concentration‐dependent manner. The results of in vivo activity further explained that B12 could inhibit the proliferation of the T98G. The pKa values of B6 , B8 , B10 , and B12 were 7.17 to 7.35, which were within the ideal range of glioma drugs. The ADME predictions indicated that these derivatives could pass through the blood‐brain barrier. In addition, molecular docking primarily explained interaction between compounds and protein. These results suggested that B12 should be a promising candidate that merits further attention in the development of anti‐glioma drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Guangdong Pharmaceutical University, 280 Outer Ring East Road, University City, Guangzhou, Guangdong Province.
- Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, 280 Outer Ring East Road, University City, Guangzhou, Guangdong Province.
Förderung
- Guangdong Pharmaceutical University-Special Innovation Project of Guangdong Education Department
- General Colleges and Universities in Guangdong Province
- Guangdong Provincial Bureau of traditional Chinese Medicine
Zitieren
APA
Ou, J., Tan, W., Chen, G., Yang, X., Luo, Y., Jin, X., & Ye, L. (2023). Design, Synthesis, and Bioactivity Evaluation of Novel Rosin Diterpenoid Derivatives as Potential Anti‐glioma Agents. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202300942
Vancouver
Ou J, Tan W, Chen G, Yang X, Luo Y, Jin X, et al. Design, Synthesis, and Bioactivity Evaluation of Novel Rosin Diterpenoid Derivatives as Potential Anti‐glioma Agents. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202300942
BibTeX
@article{Ou2023,
author = {Ou, Jiayi and Tan, Weiyun and Chen, Gong and Yang, Xianjing and Luo, Yan and Jin, Xiaobao and Ye, Lianbao},
title = {Design, Synthesis, and Bioactivity Evaluation of Novel Rosin Diterpenoid Derivatives as Potential Anti‐glioma Agents},
journal = {Chemistry & Biodiversity},
year = {2023},
doi = {10.1002/cbdv.202300942}
}
EUVIMED